ABITEC Corporation acquires Larodan AB Research grade lipids

摘要

ABITEC Corporation has announced that it has acquired Larodan AB, a manufacturer and international marketer of state of the art, high-purity research grade lipids. This strategic acquisition will expand ABlTEC's functional lipid product offerings and scientific capabilities to better serve the pharmaceutical, nutritional and industrial market sectors. Located at the globally recognized Karolinska Institute in Stockholm, Sweden, Larodan is known for its outstanding product quality, customer-friendly approach and extensive collaborations with academic and industrial researchers. "Larodan is a world leader in the field of analytical-grade lipids and their scientific capabilities will not only expand ABlTEC's technical expertise but will also provide us with a strategic R&D location in Europe. The Larodan team has done an exceptional job in the development, manufacturing and global commercialization of their unique and highly specialized lipid reagents and we are thrilled to have them join the ABITEC team. We share a common passion for innovation and lipids, and I look forward to us working together to grow and expand their brand in the US markets and across the globe," said Jeff Walton, CEO of ABITEC. "The acquisition will undoubtedly bring ABITEC to the forefront of the high-purity lipid market.